Rani Therapeutics Holdings (RANI) Total Current Liabilities (2020 - 2026)

Rani Therapeutics Holdings has reported Total Current Liabilities for 7 years, with the latest figure at $10.6 million in Q2 2026.

• On a quarterly basis, Total Current Liabilities fell 48.42% year-over-year to $10.6 million in Q2 2026; TTM through Jun 2026 was $10.6 million, a 48.42% decrease from a year earlier, with the FY2025 full-year figure at $12.7 million, down 36.31% from the prior year.
• Total Current Liabilities was $10.6 million for Q2 2026 at Rani Therapeutics Holdings, down from $13.9 million in the prior quarter.
• The five-year high for Total Current Liabilities was $20.6 million in Q2 2025, with the low at $4.2 million in Q1 2022.
• Average Total Current Liabilities over 5 years is $11.9 million, with a median of $11.7 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2026: Total Current Liabilities surged 189.12% in 2024, then slumped 48.42% in 2026.
• Over 5 years, Total Current Liabilities stood at $4.8 million in 2022, then surged by 65.92% to $8.0 million in 2023, then soared by 148.98% to $19.9 million in 2024, then slumped by 36.31% to $12.7 million in 2025, then decreased by 16.03% to $10.6 million in 2026.
• The last three Total Current Liabilities figures came in at $10.6 million (Q2 2026), $13.9 million (Q1 2026), and $12.7 million (Q4 2025), per Business Quant data.